The rapid escalation of the Bundibugyo Ebola outbreak in the Democratic Republic of the Congo, now the country’s deadliest with over 7,000 confirmed cases and 3,400 deaths across seven provinces as of early September 2026, anchors trader sentiment on the market. Conflict-driven population movements, weak surveillance, and the absence of an approved vaccine for this strain have fueled uncontrolled spread from the Ituri epicenter into North Kivu and beyond, prompting a WHO public health emergency. Imported cases reached Uganda (outbreak since declared over) and one in France, while proximity and mobility raise risks for neighbors such as South Sudan and Rwanda. Ongoing response challenges, including health worker strikes and contact-tracing gaps, plus upcoming vaccination trials and seasonal travel patterns, remain key swing factors through year-end.